Covered recipient · General Payments record
DOROTHY I SHULMAN
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$98,332.25
- Reported across 168 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,200.00 | 1 |
| Food and Beverage | $891.26 | 12 |
| Travel and Lodging | $446.21 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $7,929.15 | 10 |
| Novo Nordisk AS | $122.83 | 1 |
| BETA BIONICS, INC. | $122.58 | 1 |
| Kyowa Kirin, Inc. | $121.82 | 1 |
| Ascendis Pharma Inc | $96.64 | 1 |
| DEXCOM, INC. | $84.14 | 1 |
| Ultragenyx Pharmaceutical Inc. | $60.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ascendis Pharma Inc | $96.64 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133847260 | CMS |
| BETA BIONICS, INC. | $122.58 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087875329 | CMS |
| Dexcom, Inc. | $84.14 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153297068 | CMS |
| Kyowa Kirin, Inc. | $121.82 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127028995 | CMS |
| Medtronic, Inc. | $151.99 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119445693 | CMS |
| Medtronic, Inc. | $279.75 | 02/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119445695 | CMS |
| Medtronic, Inc. | $41.30 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119445697 | CMS |
| Medtronic, Inc. | $29.57 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112033935 | CMS |
| Medtronic, Inc. | $20.42 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112033933 | CMS |
| Medtronic, Inc. | $42.00 | 02/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1112033937 | CMS |
| Medtronic, Inc. | $124.46 | 02/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119445699 | CMS |
| Medtronic, Inc. | $7,200.00 | 03/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1112033931 | CMS |
| Medtronic, Inc. | $24.62 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119445701 | CMS |
| Medtronic, Inc. | $15.04 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119445703 | CMS |
| Novo Nordisk Inc | $122.83 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096889738 | CMS |
| Ultragenyx Pharmaceutical Inc. | $60.31 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153289662 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.